Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: Dan Hamilton who wrote (113)	8/18/1998 4:22:00 PM
From: the Chief	Respond to of 500

This does happen occassionally on thinly traded stocks. Most of these 500/1000 share offerings are "all or none" so the buyer won't get the shares unless he bids for exactly the same number of shares, or two or more people step up to the plate and swallow the 500/1000 shares. Stop buying will ya! I'm waiting for a dip to buy more, and you keep inflating the price Yep I'm a real Market maker/mover...<gggg> the Chief

To: Dan Hamilton who wrote (113)	8/24/1998 10:42:00 AM
From: the Chief	Respond to of 500

World Heart Corp - FINANCIAL POST ARTICLE WHT Shares issued 12,243,000 Aug 21 close $12.45 Mon 24 Aug 98 In the News The Financial Post reports in its Saturday edition that the artificial heart device called HeartSaver has come a long way from its inception as a research program at the University of Ottawa. Reporter Al Toulin says that World Heart, which makes the device, went public on July 21, and expects to see the first human implant of the device in late 1999. It closed its first day on the Toronto Stock Exchange at $12.10 and was trading in the $13 range in mid-August. World Heart expanded this year to set up a manufacturing plant to begin production of the HeartSaver. The company set standards and criteria for its manufacturing activities and is continuing pre-clinical trials on the device. Chief executive Rod Bryden says it no longer is a research project. Mr Bryden says that the company now has a 22,500-square-foot plant in which 8,000-square-feet is set for manufacturing. By 2001, World Heart aims to sell 2,000 units at a cost of $65,000 each, generating $131-million in revenue and net income of $19-million. (c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com